替换螺内酯结构式为无水印图片，兼整理文件 (#1485)

替换螺内酯结构式图片为 https://commons.wikimedia.org/wiki/File:Spironolactone_Structural_Formula_V1.svg

Author: yingxue03

content/zh-cn/docs/medicine/antiandrogen/spironolactone/index.md

@@ -14,11 +14,11 @@ description: 螺内酯（Spironolactone）是雄激素受体拮抗剂，一种
 
 |    一种常见的国产螺内酯片    |
 | :--------------------------: |
-| ![20 mg](spironolactone.jpg) |
+| ![20 mg](/images/medicine/spironolactone/minsheng.jpg) |
 
 - 药品名称：螺内酯片
 - 英文名称：Spironolactone Tablets
-- [说明书](./spironolactone-zh.pdf)
+- [说明书](/documents/spironolactone-zh.pdf)
 
 ## 注意事项
 
@@ -64,10 +64,10 @@ description: 螺内酯（Spironolactone）是雄激素受体拮抗剂，一种
 - CAS：[52-01-7](https://commonchemistry.cas.org/detail?cas_rn=52-01-7)
 - 化学结构式：
 
-{{< figure src="https://scimg.chem960.com/cas/0/52-01-7.png" width="40%" >}}
+{{< figure src="/images/medicine/spironolactone/structural-formula.png" width="40%" >}}
 
 [^1]: Aly. An Introduction to Hormone Therapy for Transfeminine People [EB/OL]. *Transfeminine Science*, 2018. 中译本：《[女性倾向跨性别者的激素治疗简介](https://tfsci.mtf.wiki/articles/transfem-intro/#spironolactone)》
 [^2]: [维基百科：螺内酯的副作用（英文）](https://en.wikipedia.org/wiki/Spironolactone#Side_effects)
 [^3]: Pfizer Labs. Full Prescribing Information: Aldactone (spironolactone) [EB/OL]. *Drugs@FDA*, 2022. 中译本：《[螺内酯（Aldactone）处方说明书](https://tfsci.mtf.wiki/misc/aldactone/)》
 [^4]: Aly. A Review of Studies on Spironolactone and Testosterone Suppression in Cisgender Men, Cisgender Women, and Transfeminine People [EB/OL]. *Transfeminine Science*, 2018. 中译本：《[对有关使用螺内酯的顺性别男性、顺性别女性和女性倾向跨性别者及其睾酮水平的一系列研究的评述](https://tfsci.mtf.wiki/articles/spiro-testosterone/)》
-[^5]: Standards of Care for the Health of Transgender and Gender Diverse People, Version 8. \[DOI: <https://doi.org/10.1080/26895269.2022.2100644>]
+[^5]: Standards of Care for the Health of Transgender and Gender Diverse People, Version 8. \[DOI: <https://doi.org/10.1080/26895269.2022.2100644>]

content/zh-hant/docs/medicine/antiandrogen/spironolactone/index.md

@@ -14,7 +14,7 @@ description: 螺內酯（Spironolactone）是雄激素受體拮抗劑，一種
 
 | 一種常見的中國產螺內酯片 | Aldactone® |
 | :--: | :--: |
-| ![20 mg](spironolactone.jpg) | ![100 mg](aldactone.jpg) |
+| ![20 mg](/images/medicine/spironolactone/minsheng.jpg) | ![100 mg](/images/medicine/spironolactone/aldactone.jpg) |
 
 - 藥品名稱：螺內酯片
 - 英文名稱：Spironolactone Tablets
@@ -64,10 +64,10 @@ description: 螺內酯（Spironolactone）是雄激素受體拮抗劑，一種
 - CAS：[52-01-7](https://commonchemistry.cas.org/detail?cas_rn=52-01-7)
 - 化學構造式：
 
-{{< figure src="https://scimg.chem960.com/cas/0/52-01-7.png" width="40%" >}}
+{{< figure src="/images/medicine/spironolactone/structural-formula.png" width="40%" >}}
 
 [^1]: Aly. (2018). An Introduction to Hormone Therapy for Transfeminine People. *Transfeminine Science*. 中譯本：《[女性傾向跨性別者的激素治療簡介](https://tfsci.mtf.wiki/articles/transfem-intro/#spironolactone)》
 [^2]: [維基百科：螺內酯的副作用（英文）](https://en.wikipedia.org/wiki/Spironolactone#Side_effects)
 [^3]: Pfizer Labs. (2022). Full Prescribing Information: Aldactone (spironolactone). *Drugs@FDA*. 中譯本：《[螺內酯（Aldactone）處方說明書](https://tfsci.mtf.wiki/misc/aldactone/)》
 [^4]: Aly. (2018). A Review of Studies on Spironolactone and Testosterone Suppression in Cisgender Men, Cisgender Women, and Transfeminine People. *Transfeminine Science*. 中譯本：《[對有關使用螺內酯的順性別男性、順性別女性和女性傾向跨性別者及其睪固酮水平的一系列研究的評述](https://tfsci.mtf.wiki/articles/spiro-testosterone/)》
-[^5]: Standards of Care for the Health of Transgender and Gender Diverse People, Version 8. \[DOI: <https://doi.org/10.1080/26895269.2022.2100644>]
+[^5]: Standards of Care for the Health of Transgender and Gender Diverse People, Version 8. \[DOI: <https://doi.org/10.1080/26895269.2022.2100644>]